Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder
In this article, we report a case of RP in a 7-year-old boy with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) that developed during atomoxetine (ATX) monotherapy as dose dependent and resolved with the discontinuation of medication. Case Presentation B. is a 7-y...
Gespeichert in:
| Veröffentlicht in: | Journal of child and adolescent psychopharmacology 2019-10, Vol.29 (8), p.649-650 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 650 |
|---|---|
| container_issue | 8 |
| container_start_page | 649 |
| container_title | Journal of child and adolescent psychopharmacology |
| container_volume | 29 |
| creator | Gülle, Zeynep Nur Karayagmurlu, Ali Coskun, Murat |
| description | In this article, we report a case of RP in a 7-year-old boy with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) that developed during atomoxetine (ATX) monotherapy as dose dependent and resolved with the discontinuation of medication. Case Presentation B. is a 7-year-old boy with ASD presented with his mother due to behavioral problems, including hyperactivity, impulsivity, and aggressive behaviors toward his peers. According to the report, a 10-year-old girl developed RP soon after a dosage increase and symptoms disappeared when the medication was stopped (Gokcen et al. 2013). |
| doi_str_mv | 10.1089/cap.2019.0025 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2251124601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2251124601</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-f6c7a4c72b435c7d3d331e80f687a4a7a5353d48a4a84e423c30cb0a2170e8233</originalsourceid><addsrcrecordid>eNpdkUFrFTEQgIMotj49epWAB3vZ1yST7GaP5dVaoaCUeg552Vleym7yTLLVh3_ePNp68DDMMHwzDPMR8p6zNWe6P3d2vxaM92vGhHpBTrlSXaP7XrysNZOyUbKFE_Im53vGOLSsfU1OgItW6h5OyZ9bewh2GT5l-n2HIc41Ar3FyRYc6C9fdvSixDn-xuID0ruEtlSmUB-opZudn56ppfg8UxuGOlAq4WNoLnH0zpfz68Mek3XFP_hyoJc-xzRgektejXbK-O4pr8iPq893m-vm5tuXr5uLm8aB4KUZW9dZ6TqxlaBcN8AAwFGzsdW1bzurQMEgda21RCnAAXNbZgXvGGoBsCJnj3v3Kf5cMBcz--xwmmzAuGQjhOJcyLa-Z0U-_ofexyWFep0RUL8smdJHqnmkXIo5JxzNPvnZpoPhzBytmGrFHK2Yo5XKf3jaumxnHP7RzxrgLw0fiFY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2301940581</pqid></control><display><type>article</type><title>Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder</title><source>Alma/SFX Local Collection</source><creator>Gülle, Zeynep Nur ; Karayagmurlu, Ali ; Coskun, Murat</creator><creatorcontrib>Gülle, Zeynep Nur ; Karayagmurlu, Ali ; Coskun, Murat</creatorcontrib><description>In this article, we report a case of RP in a 7-year-old boy with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) that developed during atomoxetine (ATX) monotherapy as dose dependent and resolved with the discontinuation of medication. Case Presentation B. is a 7-year-old boy with ASD presented with his mother due to behavioral problems, including hyperactivity, impulsivity, and aggressive behaviors toward his peers. According to the report, a 10-year-old girl developed RP soon after a dosage increase and symptoms disappeared when the medication was stopped (Gokcen et al. 2013).</description><identifier>ISSN: 1044-5463</identifier><identifier>EISSN: 1557-8992</identifier><identifier>DOI: 10.1089/cap.2019.0025</identifier><identifier>PMID: 31264893</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Attention deficit hyperactivity disorder ; Autism ; Autistic children ; Case reports ; Dopamine ; Dosage ; Drug dosages ; Hyperactivity ; Impulsive behavior ; Pediatrics ; Raynaud disease</subject><ispartof>Journal of child and adolescent psychopharmacology, 2019-10, Vol.29 (8), p.649-650</ispartof><rights>Copyright Mary Ann Liebert, Inc. Oct 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c321t-f6c7a4c72b435c7d3d331e80f687a4a7a5353d48a4a84e423c30cb0a2170e8233</citedby><cites>FETCH-LOGICAL-c321t-f6c7a4c72b435c7d3d331e80f687a4a7a5353d48a4a84e423c30cb0a2170e8233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31264893$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gülle, Zeynep Nur</creatorcontrib><creatorcontrib>Karayagmurlu, Ali</creatorcontrib><creatorcontrib>Coskun, Murat</creatorcontrib><title>Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder</title><title>Journal of child and adolescent psychopharmacology</title><addtitle>J Child Adolesc Psychopharmacol</addtitle><description>In this article, we report a case of RP in a 7-year-old boy with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) that developed during atomoxetine (ATX) monotherapy as dose dependent and resolved with the discontinuation of medication. Case Presentation B. is a 7-year-old boy with ASD presented with his mother due to behavioral problems, including hyperactivity, impulsivity, and aggressive behaviors toward his peers. According to the report, a 10-year-old girl developed RP soon after a dosage increase and symptoms disappeared when the medication was stopped (Gokcen et al. 2013).</description><subject>Attention deficit hyperactivity disorder</subject><subject>Autism</subject><subject>Autistic children</subject><subject>Case reports</subject><subject>Dopamine</subject><subject>Dosage</subject><subject>Drug dosages</subject><subject>Hyperactivity</subject><subject>Impulsive behavior</subject><subject>Pediatrics</subject><subject>Raynaud disease</subject><issn>1044-5463</issn><issn>1557-8992</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkUFrFTEQgIMotj49epWAB3vZ1yST7GaP5dVaoaCUeg552Vleym7yTLLVh3_ePNp68DDMMHwzDPMR8p6zNWe6P3d2vxaM92vGhHpBTrlSXaP7XrysNZOyUbKFE_Im53vGOLSsfU1OgItW6h5OyZ9bewh2GT5l-n2HIc41Ar3FyRYc6C9fdvSixDn-xuID0ruEtlSmUB-opZudn56ppfg8UxuGOlAq4WNoLnH0zpfz68Mek3XFP_hyoJc-xzRgektejXbK-O4pr8iPq893m-vm5tuXr5uLm8aB4KUZW9dZ6TqxlaBcN8AAwFGzsdW1bzurQMEgda21RCnAAXNbZgXvGGoBsCJnj3v3Kf5cMBcz--xwmmzAuGQjhOJcyLa-Z0U-_ofexyWFep0RUL8smdJHqnmkXIo5JxzNPvnZpoPhzBytmGrFHK2Yo5XKf3jaumxnHP7RzxrgLw0fiFY</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Gülle, Zeynep Nur</creator><creator>Karayagmurlu, Ali</creator><creator>Coskun, Murat</creator><general>Mary Ann Liebert, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7RV</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201910</creationdate><title>Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder</title><author>Gülle, Zeynep Nur ; Karayagmurlu, Ali ; Coskun, Murat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-f6c7a4c72b435c7d3d331e80f687a4a7a5353d48a4a84e423c30cb0a2170e8233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Attention deficit hyperactivity disorder</topic><topic>Autism</topic><topic>Autistic children</topic><topic>Case reports</topic><topic>Dopamine</topic><topic>Dosage</topic><topic>Drug dosages</topic><topic>Hyperactivity</topic><topic>Impulsive behavior</topic><topic>Pediatrics</topic><topic>Raynaud disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gülle, Zeynep Nur</creatorcontrib><creatorcontrib>Karayagmurlu, Ali</creatorcontrib><creatorcontrib>Coskun, Murat</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of child and adolescent psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gülle, Zeynep Nur</au><au>Karayagmurlu, Ali</au><au>Coskun, Murat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder</atitle><jtitle>Journal of child and adolescent psychopharmacology</jtitle><addtitle>J Child Adolesc Psychopharmacol</addtitle><date>2019-10</date><risdate>2019</risdate><volume>29</volume><issue>8</issue><spage>649</spage><epage>650</epage><pages>649-650</pages><issn>1044-5463</issn><eissn>1557-8992</eissn><abstract>In this article, we report a case of RP in a 7-year-old boy with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) that developed during atomoxetine (ATX) monotherapy as dose dependent and resolved with the discontinuation of medication. Case Presentation B. is a 7-year-old boy with ASD presented with his mother due to behavioral problems, including hyperactivity, impulsivity, and aggressive behaviors toward his peers. According to the report, a 10-year-old girl developed RP soon after a dosage increase and symptoms disappeared when the medication was stopped (Gokcen et al. 2013).</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>31264893</pmid><doi>10.1089/cap.2019.0025</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1044-5463 |
| ispartof | Journal of child and adolescent psychopharmacology, 2019-10, Vol.29 (8), p.649-650 |
| issn | 1044-5463 1557-8992 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2251124601 |
| source | Alma/SFX Local Collection |
| subjects | Attention deficit hyperactivity disorder Autism Autistic children Case reports Dopamine Dosage Drug dosages Hyperactivity Impulsive behavior Pediatrics Raynaud disease |
| title | Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T05%3A50%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Raynaud's%20Phenomenon%20Related%20with%20Atomoxetine%20Treatment%20in%20a%20Child%20with%20Autism%20and%20Attention-Deficit/Hyperactivity%20Disorder&rft.jtitle=Journal%20of%20child%20and%20adolescent%20psychopharmacology&rft.au=G%C3%BClle,%20Zeynep%20Nur&rft.date=2019-10&rft.volume=29&rft.issue=8&rft.spage=649&rft.epage=650&rft.pages=649-650&rft.issn=1044-5463&rft.eissn=1557-8992&rft_id=info:doi/10.1089/cap.2019.0025&rft_dat=%3Cproquest_cross%3E2251124601%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2301940581&rft_id=info:pmid/31264893&rfr_iscdi=true |